lbusch@blue.weeg.uiowa.edu
Mentor: Gail Bishop, Ph.D.
Lab Phone: 335-7816

Stunz LL, Busch LK, Munroe ME, Sigmund CD, Tygrett LT, Waldschmidt TJ, Bishop GA. Expression of the cytoplasmic tail of LMP1 in mice induces hyperactivation of B lymphocytes and disordered lymphoid architecture. Immunity. 2004 Aug;21(2):255-66. PubMed PMID: 15308105.

Bishop GA, Busch LK. Molecular mechanisms of B-lymphocyte transformation by Epstein-Barr virus. Microbes Infect. 2002 Jul;4(8):853-7. Review. PubMed PMID: 12270732.

Busch LK, Bishop GA. Multiple carboxyl-terminal regions of the EBV oncoprotein, latent membrane protein 1, cooperatively regulate signaling to B lymphocytes via TNF receptor-associated factor (TRAF)-dependent and TRAF-independent mechanisms. J Immunol. 2001 Nov 15;167(10):5805-13. PubMed PMID:11698454.

Bishop GA, Ramirez LM, Baccam M, Busch LK, Pederson LK, Tomai MA. The immune response modifier resiquimod mimics CD40-induced B cell activation. Cell Immunol. 2001 Feb 25;208(1):9-17. PubMed PMID: 11277614.

Busch LK, Bishop GA. The EBV transforming protein, latent membrane protein 1, mimics and cooperates with CD40 signaling in B lymphocytes. J Immunol. 1999 Mar 1;162(5):2555-61. PubMed PMID: 10072495.